Site Search

 

 

 

 

 

Home
General Topics
       Residual Renal Function
          The Importance of RRF
          Contrast Media
       Diabetes Management
          General Facts
          Pathophysiology
          PD and the Diabetic Patient
       Renal Osteodystrophy
          Renal Osteodystrophy Clinical Studies
       Numbers-Their Use and Interpretation
       Basic Statistics
       Choices for Home Dialysis
       Other
          Vaccinating CKD and Dialysis Patients
          32 yr dialysis patient receives Achievement award
Peritoneal Dialysis
       History of PD
          PD - The Foundations
          Early Clinical Experiences with PD
       Kinetic Principles
          Basic Principles of PD
             What is Dialysis?
             Anatomy of the Peritoneum
             Physiology of the Peritoneum
          StdKt/V - Dose Equivalency
       Peritoneal Transport 
          Understanding Testing Methods
          Prognostic Value of Transport Status
          Peritoneal Function After Exposure to PD
       Modalities of Therapy
          PD Techniques
          PD Modalities
       PD Adequacy
          Prescribing Dialysis
             Targets of PD Prescription
             Determinants of Dose
             Exchange Volume and Position
             How to Reach the Goals
             Monitoring the PD Patient
             Evaluating the Patient as a Whole
             Response to Inadequate Peritoneal Dialysis
          Difficulties in Providing Adequate Dialysis
       Ultrafiltration
          Importance of Volume Control
          How to Achieve Adequate PD UF
       Clinical Procedures
       Complications
          Non-Infectious Complications of PD
          Peritoneal Dialysis-Related Infections
             Peritonitis
             Management of ESI
       Dialysis Access
          The Evolution of PD Catheters
          Preop Management
          Placement of PD Catheters
          Intraoperative Management
          Post Operative Care and Management
          Complications of PD Catheters
       Clinical Outcomes
          Clinical outcomes of PD and HD
       Peritoneal Dialysis in Children
          Pediatric ESRD Incidence, Prevalence and Mortality
          Management of the pediatric patient on PD
          Utilization of PD for Acute Renal Failure and ESRD
          Prescription principles, adequacy and PET
          Additional care considerations: Nutrition, Growth,
       Dialysis Equipment & Disposables
          PD Solutions
       PD in the ICU
       Home Program Management
Hemodialysis
       History of Hemodialysis
       Kinetic Principles
          Impact of t & Kr on Kt/V
          StdKt/V - Dose Equivalency
       Modalities of Therapy
          Hemodialysis Regimens/Prescriptions
          Extracorporeal Modalities
       Home HD
          Introduction
          HD Regimens/Prescriptions
          The Influence of Dose, Time & Frequency
          Every other day HD (HD3.5)
          Time Versus Dialysis-Free Interval
          Benefits of Increased HD Frequency
          Increased Frequency – Other Modalities
          Potential Lifestyle Benefits of HD3.5
          Home Program Management
             Establishing a Home Program
       Intradialytic Complications
       Adequacy
          Difficulties in Prescribing Adequate Dialysis
       Sodium Modeling
       Hemodialysis Access
          Introduction to Vascular Access
          Overview of Arteriovenous Fistula
          Overview of Arteriovenous Grafts
          Overview of Central Venous Catheters
          Vascular Access Monitoring and Surveillance
       Access Complications
          Overview of Hemodialysis Complications
          AVF Stenosis
          Interventions for AVF and AVG Stenosis
          Primary Fistula Failure
          Catheter Related Bacteremia
Sorbent Technology
       History of Sorbent Technology
Seminars & Education
       WebEx Physician Courses
       WebEx Teleconference Workshops
       Online Nursing Courses
Educational Initiatives
Training Resources
       Kidney Options Kidney Options
       Patient Training Resources
       Training Resources for Professionals Training Resources for Professionals
Product Information
       Peritoneal Dialysis
          Fresenius Peritoneal Dialysis Connections
       Hemodialysis
Glossary
Links
       Journals
       Organizations
       Other Links
Contact Information
Calendar of Events
Contributors
Peritoneal Dialysis > PD Adequacy > Prescribing Dialysis > Response to Inadequate Peritoneal Dialysis

Response to Inadequate Peritoneal Dialysis

Since the publication of the initial National Kidney Foundations Dialysis Outcomes Quality Initiatives (KDOQI) Guidelines for Adequacy of Peritoneal Dialysis (PD)1 there has been a positive trend to increase the frequency of monitoring and the dose of delivered dialysis among PD patients in the US.  Data from the Centers for Medicare and Medicaid for the year 2000 and the ESRD Clinical Performance Measures Project Annual Report for 2004 were used to obtain information on dialysis prescriptions and adequacy2,3.  

 

The dose of dialysis prescribed and delivered has significantly increased since the original publication of the KDOQI guidelines in 1997.  The percentage of CAPD patients that met the guidelines for Kt/V or that the dialysis prescription was changed if the adequacy measurements were less than these thresholds during the six month study period increased from 23% in 1995 to 70% in 20042,4.  Similarly, cycler patients have increased from 28 to 65% during that period of time.

 

Response to inad PD 1.gif

 Percent of patients meeting KDOQI guidelines

 

The principal means to increase the PD dose include an increase in the number of daily exchanges, higher exchange volumes and a combination of these two maneuvers.  As of March 2004, only 11% of all patients used less than 8,000 ml of PD solution per day, 33% used 8,000 ml and 66% more than 8,000 ml.  Among adult CAPD patients the single dwell volume was < 2,000 ml in 50% of the patients and exceeded 2,000 ml in the other 50%.  The mean single night-time dwell volume for adult patients on cycler therapy exceeded 2,500 ml in 42%. 

 

Response to inad PD 2.gif

 Distribution of 24-hour total infused dialysate volumes for adult CAPD patients, Oct 2003 - Mar 2004 (2004 ESRD CPM Project)

 

Response to inad PD 3.gif

Distribution of single dwell volumes for adult CAPD patients, Oct 2003 - Mar 2004 (2004 ESRD CPM Project)

 

Among adult cycler patients the mean number of night-time exchanges was three exchanges in 13%, four in 43% and five or more in 37% and the mean number of day-time exchanges was two or more in 42%.  These trends towards utilization of larger volumes of dialysate, particularly at night and in the supine position, reflect the emphasis on good dialysis practices.  There are insufficient data to establish trends on volume control and net ultrafiltration.

 

Response to inad PD 4.gif

Distribution of mean number of day-time exchanges for adult cycler patients with a day-time dwell, Oct 2003 - Mar 2004 (2004 ESRD CPM Project)

 

Response to inad PD 5.gif

Distribution of mean single day-time dwell volumes for adult cycler patients with a day-time dwell, Oct 2003 - Mar 2004 (2004 ESRD CPM Project)

 

Response to inad PD 6.gif

Distribution of mean number of nighttime exchanges for adult cycler patients, Oct 2003 - Mar 2004 (2004 ESRD CPM Project)

 

Response to inad PD 7.gif

 Distribution of mean single nighttime dwell volumes for adult cycler patients, Oct 2003 - Mar 2004 (2004 ESRD CPM Project)

 

 

References:

  1. NKF DOQI. Clinical Practice Guidelines for Peritoneal Dialysis Adequacy. Am J Kidney Dis 30:S67-S136, 1997
  2. Rocco MV, Frankenfield DL, Prowant B, et al.  Response to inadequate dialysis in chronic peritoneal dialysis patients.  Results from the 2000 centers for Medicare and Medicaid (CMS) ESRD Peritoneal Dialysis Clinical Performance Measures (PD-CPM) Project. Am J Kidney Dis 41:840-848, 2003
  3. Centers for Medicare & Medicaid Services: 2004 Annual Report, End-Stage Renal Disease Clinical Performance Measures Project. Am J Kidney Dis 46 (Suppl 2):1-100, 2005
  4. Health Care Financing Administration: 2000 Annual Report, End-Stage Renal Disease Clinical Performance Measures Project, Baltimore, MD-44, Department of Health and Human Services, Health Care Financing Administration, Office of Clinical Standards and Quality, 2000

 

 

 

Print  
© 2006-2010, Fresenius Medical Care North America. All Rights Reserved. | Terms Of Use | Privacy Statement | Register | Login